An “immuno-storm chip” developed by University of Queensland researchers could diagnose cancer and COVID-19 patients at risk of a potentially lethal reaction.
A significant number of non-Hodgkin lymphoma (NHL) patients in a Penn Medicine-initiated clinical trial continue to be in remission five years after receiving the chimeric antigen […]
Researchers from the University of Helsinki have demonstrated the possibilities of artificial intelligence-based algorithms in predicting the efficacy of a targeted cancer therapy based on the […]